Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -11.70 is 97% above its 5-year average of -340.02, near the high end of its 5-year range (-564.68–-10.61).
75.72% above its 12-month average of -48.19.
Reported quarterly EPS; no daily interpolation. Q1 FY2027 (2026-06-30): -4.02.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-11.70
EARNINGS PER SHARE (EPS) AVG TTM
-48.19
EARNINGS PER SHARE (EPS) AVG 3Y
-238.41
EARNINGS PER SHARE (EPS) AVG 5Y
-340.02
EARNINGS PER SHARE (EPS) AVG 10Y
-185.47
EARNINGS PER SHARE (EPS) AVG 15Y
-200.16
EARNINGS PER SHARE (EPS) AVG 20Y
-1366.24
CURRENT VS TTM AVG
+75.72%
CURRENT VS 3Y AVG
+95.09%
CURRENT VS 5Y AVG
+96.56%
CURRENT VS 10Y AVG
+93.69%
CURRENT VS 15Y AVG
+94.15%
CURRENT VS 20Y AVG
+99.14%
Aethlon Medical, Inc.
Market Cap
$3.28M
Earnings Per Share (EPS)
-11.70
TTM Avg
-48.19
3Y Avg
-238.41
5Y Avg
-340.02
Market Cap
$3.27M
Earnings Per Share (EPS)
-6.76
TTM Avg
-8.05
3Y Avg
-9.85
5Y Avg
-9.67
Market Cap
$3.21M
Earnings Per Share (EPS)
-4.90
TTM Avg
-7.69
3Y Avg
-8.41
5Y Avg
-8.41
Market Cap
$3.21M
Earnings Per Share (EPS)
N/A
TTM Avg
-12.74
3Y Avg
-17.52
5Y Avg
-18.26
Market Cap
$3.46M
Earnings Per Share (EPS)
N/A
TTM Avg
-130.80
3Y Avg
-71.47
5Y Avg
-57.18
Market Cap
$3.49M
Earnings Per Share (EPS)
-14.40
TTM Avg
-19.95
3Y Avg
-16.43
5Y Avg
-17.45
Market Cap
$3.49M
Earnings Per Share (EPS)
-0.45
TTM Avg
-1.48
3Y Avg
-5.05
5Y Avg
-8.12
Market Cap
$3.52M
Earnings Per Share (EPS)
-0.91
TTM Avg
-1.99
3Y Avg
-3.92
5Y Avg
-2.83
Market Cap
$2.98M
Earnings Per Share (EPS)
-22.20
TTM Avg
-27.40
3Y Avg
-44.30
5Y Avg
-249.07
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aethlon Medical, Inc. (AEMD) | $3.28M | -11.70 | -48.19 | -238.41 | -340.02 |
| IceCure Medical Ltd (ICCM)vs › | $3.27M | -6.76 | -8.05 | -9.85 | -9.67 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.21M | -4.90 | -7.69 | -8.41 | -8.41 |
| MBody AI Ltd. (MBAI)vs › | $3.21M | N/A | -12.74 | -17.52 | -18.26 |
| Moolec Science S.A. (MLEC)vs › | $3.46M | N/A | -130.80 | -71.47 | -57.18 |
| Nexalin Technology, Inc. (NXL)vs › | $3.49M | -14.40 | -19.95 | -16.43 | -17.45 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -0.45 | -1.48 | -5.05 | -8.12 |
| Evogene Ltd. (EVGN)vs › | $3.52M | -0.91 | -1.99 | -3.92 | -2.83 |
| BioRestorative Therapies, Inc. (BRTX)vs › | $2.98M | -22.20 | -27.40 | -44.30 | -249.07 |
| Eocene Ltd. (EOCN)vs › | $3.57M | N/A | N/A | N/A | N/A |
Trailing EPS (TTM)
$-11.70
Forward EPS (Est.)
$-6.49
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-03-31 | -10.61 |
| 2025-03-31 | -85.77 |
| 2024-03-31 | -388.67 |
| 2023-03-31 | -468.60 |
| 2022-03-31 | -564.68 |
| 2021-03-31 | -521.81 |
| 2020-03-31 | 0.00 |
| 2019-03-31 | 0.00 |
| 2018-03-31 | 0.00 |
| 2017-03-31 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-03-31 | -516.22 |
| 2013-03-31 | -245.88 |
| 2012-03-31 | -2989.00 |
| 2011-03-31 | -3077.00 |
| 2010-03-31 | -3029.00 |
| 2009-03-31 | -5312.50 |
| 2008-03-31 | -4514.00 |
| 2007-03-31 | -8387.00 |
| 2006-03-31 | -5601.00 |
| 2005-03-31 | -5602.00 |
| 2004-03-31 | -6962.00 |
| 2003-03-31 | -16620.00 |
| 2002-03-31 | -39030.00 |
| 2001-03-31 | -457875.00 |
| 2000-03-31 | -18653.00 |
| 1999-03-31 | -8777.50 |
| 1998-03-31 | -71080.00 |
| 1997-03-31 | -45.00 |
